Chapter 49: Immunizing Drugs
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The content distinguishes between two primary immunization approaches: active immunization, in which vaccines and toxoids stimulate the immune system to generate its own antibody response and establish immunological memory, and passive immunization, which delivers pre-formed antibodies through immunoglobulins, antitoxins, or antivenins to provide immediate but short-term protection. The chapter explains the underlying immunological mechanisms, including humoral and cell-mediated immune responses, the development of memory cells that enable long-lasting immunity after vaccination, and the epidemiological concept of herd immunity whereby widespread immunization protects even unvaccinated community members. The presentation of active immunizing agents covers vaccines and toxoids for major infectious diseases including diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, seasonal influenza, measles-mumps-rubella, meningococcal infection, pneumococcal disease, poliomyelitis, rabies, human papillomavirus, herpes zoster, and varicella. Passive immunizing drugs, such as hepatitis B immunoglobulin, Rh factor immunoglobulin, rabies immunoglobulin, tetanus immunoglobulin, varicella-zoster immunoglobulin, and specialized antivenins, are discussed for their rapid therapeutic action in post-exposure or high-risk scenarios. Critical nursing considerations encompass patient assessment for contraindications including allergies, pregnancy status, and immunocompromised conditions; management of adverse effects ranging from localized injection site reactions to rare severe complications such as serum sickness and anaphylaxis; appropriate vaccine storage and cold chain maintenance; proper administration technique; booster scheduling; and complete documentation of immunization status. The chapter addresses contemporary public health issues including vaccine hesitancy, adverse event reporting through VAERS systems, and evidence-based responses to vaccine safety concerns. This comprehensive integration of pharmacological, immunological, and nursing knowledge prepares students to administer immunizing drugs safely, educate patients effectively, and contribute to disease prevention and global health protection.